"Chestnut Hill Hospital is a 148-bed, community-based, university-affiliated, teaching hospital committed to excellent patient-centered care. Chestnut Hill Hospital provides a full range of inpatient and outpatient, diagnostic and treatment services for people in northwest Philadelphia and eastern Montgomery County. With more 300 board-certified physicians, Chestnut Hill Hospital’s specialties include minimally invasive laparoscopic and robotic surgery, cardiology, gynecology, oncology, orthopedics, urology, family practice and internal medicine."

During the past decade, Chestnut Hill Health System conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chestnut Hill Health System" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Chestnut Hill Health System" with 2 trials sponsored, "University of Pennsylvania" with 2 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Vertos Medical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chestnut Hill Health System" #1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "NSABP Foundation Inc" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Chestnut Hill Health System" are "Hyperlipidemia" (2 trials), "Breast Adenocarcinoma" (1 trials), "Catheter-Related Infections" (1 trials), "Colon Mucinous Adenocarcinoma" (1 trials) and "Colon Signet Ring Cell Adenocarcinoma" (1 trials). Many other conditions were trialed in "Chestnut Hill Health System" in a lesser frequency.

Most popular intervention types in "Chestnut Hill Health System" are "Drug" (10 trials), "Other" (6 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Bevacizumab" (3 trials), "Quality-of-Life Assessment" (3 trials), "Exemestane" (2 trials) and "Radiation Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chestnut Hill Health System" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Chestnut Hill Health System". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Chestnut Hill Health System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chestnut Hill Health System, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Chestnut Hill Health System has several departments that took part in Clinical trials: "Pottstown Memorial Regional Cancer Center" - 30 trials, "Cancer Center at Phoenixville Hospital" - 12 trials